Insufficient scRNA-seq data for expression of PCDHGC3 at single-cell level.
Insufficient scRNA-seq data for expression of PCDHGC3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 4000.63 | 2621 / 2642 | 99% | 215.98 | 698 / 705 |
skin | 99% | 1942.50 | 1797 / 1809 | 92% | 65.94 | 436 / 472 |
esophagus | 99% | 1544.44 | 1424 / 1445 | 74% | 18.40 | 135 / 183 |
breast | 99% | 1590.43 | 454 / 459 | 66% | 9.69 | 740 / 1118 |
lung | 100% | 3188.69 | 576 / 578 | 64% | 9.87 | 738 / 1155 |
prostate | 94% | 1160.95 | 230 / 245 | 68% | 9.36 | 343 / 502 |
adrenal gland | 91% | 1332.40 | 234 / 258 | 57% | 13.40 | 130 / 230 |
uterus | 99% | 2327.96 | 169 / 170 | 47% | 7.90 | 217 / 459 |
thymus | 95% | 946.20 | 619 / 653 | 51% | 7.40 | 307 / 605 |
ovary | 97% | 1271.71 | 174 / 180 | 45% | 6.01 | 192 / 430 |
bladder | 100% | 1584.43 | 21 / 21 | 36% | 4.54 | 183 / 504 |
pancreas | 53% | 313.15 | 174 / 328 | 75% | 9.59 | 134 / 178 |
intestine | 88% | 1126.45 | 854 / 966 | 38% | 4.81 | 198 / 527 |
stomach | 60% | 754.63 | 215 / 359 | 51% | 7.76 | 147 / 286 |
kidney | 36% | 250.94 | 32 / 89 | 70% | 14.93 | 631 / 901 |
adipose | 100% | 1627.81 | 1200 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1892.46 | 1326 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 42.08 | 79 / 80 |
heart | 85% | 931.08 | 731 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 56% | 8.31 | 25 / 45 |
muscle | 41% | 265.69 | 327 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 31% | 3.90 | 9 / 29 |
spleen | 27% | 147.73 | 65 / 241 | 0% | 0 | 0 / 0 |
liver | 8% | 44.87 | 18 / 226 | 8% | 0.93 | 33 / 406 |
peripheral blood | 7% | 43.84 | 65 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
GO_0007155 | Biological process | cell adhesion |
GO_0050808 | Biological process | synapse organization |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0007399 | Biological process | nervous system development |
GO_0016339 | Biological process | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005509 | Molecular function | calcium ion binding |
Gene name | PCDHGC3 |
Protein name | Protocadherin gamma-C3 (PCDH-gamma-C3) (Protocadherin-2) (Protocadherin-43) (PC-43) Protocadherin gamma subfamily C, 3 |
Synonyms | PCDH2 |
Description | FUNCTION: Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain. |
Accessions | Q9UN70 A0A087X1P2 ENST00000308177.5 [Q9UN70-1] ENST00000617641.4 Q9BR81 ENST00000611950.1 [Q9UN70-2] A0A087WYB5 ENST00000621008.1 ENST00000617222.4 |